Trial Profile
Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Dec 2010 Planned end date changed from 1 Jun 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.